Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,358.00    -25.00 (-1.05%)
Bid:
2,363.00
Ask:
2,364.00
Spread: 1.00 (0.042%)
Market Cap: £28.44b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Statement re CMA Final Determinations

28 Oct 2021 07:03

RNS Number : 4990Q
SSE PLC
28 October 2021
 

SSE plc

CMA Final Determinations

28 October 2021

 

The CMA has today published a summary of its final determinations into SSEN Transmission's appeal against certain elements of Ofgem's RIIO-T2 price control settlement. The full final determinations and associated documents are expected to be provided to appellants and interveners later this week and then published by the CMA shortly thereafter.

SSEN Transmission welcomes that the CMA has upheld its appeals against the assumed 'Outperformance Wedge', and for changes to the Licence Modification Process.

However, SSEN Transmission is disappointed that the CMA has not upheld its appeals on the flawed Cost of Equity, or on changes to how Transmission Network Use of System Charges are recovered and the associated risk of under recovery this presents.

SSEN Transmission will continue to assess the full details of the CMA's final determinations as they become available and remains committed to work constructively with Ofgem and wider stakeholders as it continues to take forward ambitious plans to deliver a network for net zero.

ENQUIRIES:

Investors and Analysts ir@sse.com +44(0)345 0760 530

Media media@sse.com +44(0)345 0760 530

NOTES TO EDITORS:

SSEN Transmission, operating under licence held by Scottish Hydro Electric (SHE) Transmission plc, owns, operates and develops the high voltage electricity transmission system in the north of Scotland and remote islands.

SSEN Transmission is a wholly owned subsidiary of SSE plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFEAIFLDFIL
Date   Source Headline
29th Sep 20217:00 amRNSNotification of Closed Period
29th Sep 20217:00 amRNSSSE Renewables enter Japanese offshore wind market
20th Sep 20217:00 amRNSResponse to media speculation
17th Sep 20214:52 pmRNSDirector/PDMR Shareholding
15th Sep 20211:37 pmRNSDirector/PDMR Shareholding
14th Sep 20214:30 pmRNSAdditional Listing
2nd Sep 20219:18 amRNSFinal Dividend Scrip Take-Up
1st Sep 202111:12 amRNSBlock-Listing Six-Monthly Return
1st Sep 202111:06 amRNSTotal Voting Rights
11th Aug 20214:35 pmRNSDirector/PDMR Shareholding
11th Aug 20217:12 amRNSStatement re CMA Provisional Findings
5th Aug 20212:33 pmRNSScrip Reference Price
4th Aug 20211:17 pmRNSHolding(s) in Company
4th Aug 202110:23 amRNSHolding(s) in Company
3rd Aug 20214:38 pmRNSHolding(s) in Company
2nd Aug 20212:31 pmRNSTotal Voting Rights
2nd Aug 20217:04 amRNSSSE AGREES SALE OF STAKE IN SGN FOR £1.225BN
27th Jul 20215:09 pmRNSHolding(s) in Company
22nd Jul 20213:19 pmRNSResults of AGM
22nd Jul 20217:00 amRNSTrading Statement
8th Jul 202112:10 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSSSEN Distribution publishes business plan
1st Jul 20217:00 amRNSTotal Voting Rights
30th Jun 20213:42 pmRNSDirector/PDMR Shareholding
30th Jun 202110:00 amRNSDirector Declaration
24th Jun 20214:03 pmRNSBoard Appointments
18th Jun 202112:00 pmRNSPublication of Annual Report and Accounts 2021
8th Jun 20213:22 pmRNSDirector/PDMR Shareholding
1st Jun 20214:00 pmRNSTotal Voting Rights
1st Jun 20213:12 pmRNSDirector/PDMR Shareholding
26th May 20214:11 pmRNSDirector/PDMR Shareholding
26th May 20214:10 pmRNSFinal Dividend Timetable FYE 31 March 2021
26th May 20217:00 amRNSPreliminary results for the year to 31 March 2021
7th May 20211:09 pmRNSDirector/PDMR Shareholding
4th May 20217:00 amRNSTotal Voting Rights
9th Apr 202111:22 amRNSDirector/PDMR Shareholding
1st Apr 20213:32 pmRNSSale of Contracting Division
1st Apr 20217:00 amRNSTotal Voting Rights
31st Mar 20214:48 pmRNSDirector/PDMR Shareholding
30th Mar 20217:00 amRNSNOTIFICATION OF CLOSED PERIOD
24th Mar 202112:37 pmRNSDirector/PDMR Shareholding
18th Mar 20214:08 pmRNSDirector/PDMR Shareholding
17th Mar 20215:12 pmRNSSSEN TRANSMISSION ISSUES NEW £500M GREEN BOND
17th Mar 20213:27 pmRNSDirector/PDMR Shareholding
16th Mar 20215:26 pmRNSPublication of a Prospectus
10th Mar 20214:32 pmRNSDirector/PDMR Shareholding
9th Mar 20219:00 amRNSDirector Declaration
5th Mar 20212:24 pmRNSAdditional Listing
2nd Mar 20212:00 pmRNSSSEN Transmission Appeals RIIOT2 to CMA
1st Mar 20217:00 amRNSBlocklisting Six-Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.